Related Experiment Video
Updated: Jun 19, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial
Sreerama Shetty1, Thirunavukkarasu Velusamy, Rashmi S Shetty
1Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler, 75708, USA. sreerama.shetty@uthct.edu
Abstract:
The plasminogen activator inhibitor type-1 (PAI-1) effectively blocks the activities of free and receptor-bound urokinase-type plasminogen activator. Incubation of cultured human pleural mesothelial (Met5A) cells with TGF-beta increased PAI-1 protein. TGF-beta, phorbol myristate acetate, and the translation inhibitor cycloheximide induced PAI-1 mRNA and slowed its degradation, suggesting that PAI-1 mRNA could be regulated by interaction of a PAI-1 binding protein (PAI-1 mRNABp) with PAI-1 mRNA. We found that an approximately 60 kD cytoplasmic PAI-1 mRNABp is detectable in cytoplasmic extracts of MeT5A human pleural mesothelial and malignant mesothelioma cells. The PAI-1 mRNABp specifically binds to a 33-nt sequence in the 3' untranslated region of PAI-1 mRNA. Insertion of this 33-nt sequence destabilizes otherwise stable beta-globin mRNA, indicating that the binding sequence accelerates decay of endogenous PAI-1 mRNA. Competitive inhibition by overexpression of the 33-nt binding sequence in MeT5A cells reduced PAI-1 mRNA decay and increased PAI-1 protein and mRNA expression, indicating that the PAI-1 mRNABp destabilizes PAI-1 mRNA by its interaction with the endogenous 33-nt binding sequence. Incubation of Met5A cells with TGF-beta attenuated the interaction of the PAI-1 mRNABp with the 33-nt sequence. By conventional and affinity purification, we isolated the PAI-1 mRNABp and confirmed its identity as 6-phospho-d-gluconate-NADP oxidoreductase, which specifically interacts with the full-length and the 33-nt sequence of the PAI-1 mRNA 3' untranslated region. This newly recognized pathway could influence expression of PAI-1 by mesothelial or mesothelioma cells at the level of mRNA stability in the context of pleural inflammation or malignancy.
Insights
A novel protein, 6-phospho-d-gluconate-NADP oxidoreductase, binds plasminogen activator inhibitor type-1 (PAI-1) mRNA, regulating its stability. This interaction influences PAI-1 expression in pleural cells, impacting inflammation and malignancy.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Plasminogen activator inhibitor type-1 (PAI-1) is a key regulator of fibrinolysis and extracellular matrix remodeling.
- PAI-1 activity is crucial in processes like inflammation and cancer, particularly in pleural diseases.
- Previous studies indicated TGF-beta influences PAI-1 protein levels, suggesting post-transcriptional regulation.
Purpose of the Study:
- To identify and characterize the protein responsible for regulating plasminogen activator inhibitor type-1 (PAI-1) mRNA stability.
- To elucidate the mechanism by which this protein interacts with PAI-1 mRNA.
- To investigate the role of this regulatory pathway in mesothelial and mesothelioma cells.
Main Methods:
- Incubation of human pleural mesothelial (Met5A) cells with TGF-beta, phorbol myristate acetate, and cycloheximide to study PAI-1 mRNA regulation.
- Detection and characterization of a PAI-1 mRNA binding protein (PAI-1 mRNABp) in cytoplasmic extracts.
- RNA-binding assays using specific PAI-1 mRNA sequences and competitive inhibition experiments.
- Protein purification and identification using conventional and affinity chromatography, followed by mass spectrometry.
Main Results:
- A ~60 kD cytoplasmic protein, PAI-1 mRNABp, was detected in mesothelial and mesothelioma cells.
- PAI-1 mRNABp specifically binds to a 33-nucleotide sequence in the 3' untranslated region of PAI-1 mRNA, which accelerates mRNA decay.
- Overexpression of the binding sequence reduced PAI-1 mRNA decay and increased PAI-1 expression; TGF-beta attenuated the mRNABp-mRNA interaction.
- The PAI-1 mRNABp was identified as 6-phospho-d-gluconate-NADP oxidoreductase.
Conclusions:
- 6-phospho-d-gluconate-NADP oxidoreductase directly regulates PAI-1 mRNA stability through interaction with its 3' UTR.
- This novel regulatory pathway influences PAI-1 expression at the mRNA level in pleural cells.
- The findings provide new insights into the control of PAI-1 in pleural inflammation and malignancy.
More Related Videos
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Regulation of Expression at Multiple Steps

